The fairness of the proposed acquisition of WebMD Health Corp. (“WBMD” or the “Company”) (NASDAQ: WBMD) by private equity firm KKR & Co. (“KKR”) is the subject of an investigation by WeissLaw LLP, a national class action and shareholder rights law firm.  The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of WBMD for agreeing to sell the Company to KKR.  On July 24, 2017, the Company announced a definitive agreement for KKR to acquire WBMD in a transaction valued at approximately $2.8 billion.  Under the terms of the agreement, WBMD shareholders will receive $66.50 in cash for each WBMD share they own.

WeissLaw is investigating whether WBMD’s Board acted to maximize shareholder value prior to entering into the agreement.  Notably, at least one analyst set a target price of $72.00 per share, or $5.50 above the offer price.  Additionally, on the same day as the acquisition announcement, WBM preliminarily reported that it expected to exceed its revenue guidance by approximately $3 million at the high-end in the second quarter of 2017.  It also announced that it anticipated annual growth of 6% and 8% in net income and adjusted EBITDA, respectively.

Given these facts, WeissLaw is investigating whether the WBMD Board acted in the best interests of WBMD’s public shareholders by actively shopping the Company to maximize shareholder value prior to entering into the agreement with KKR.  If you own WBMD shares and would like more information about your rights or our investigation, or if you have information to share with us, please contact Joshua Rubin by telephone at (888) 593-4771 or by email at stockinfo@weisslawllp.com.

WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties.  We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases.  If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at stockinfo@weisslawllp.com or fill out the form on our website, http://www.weisslawllp.com/webmd-health-corp/